Back
Gold Royalty Corp. Vs. Moderna, Inc. Industry Stock Comparison
Sell
47
GROY
Gold Royalty Corp.
Last Price:
$3.68
Seasonality Move:
-5.7%
Sell
33
MRNA
Moderna, Inc.
Last Price:
$49.23
Seasonality Move:
20.07%
Sell
47
Gold Royalty Corp. (GROY)
is a Sell
Is Gold Royalty Corp. a Buy, Sell or Hold?
-
The current Gold Royalty Corp. [GROY] share price is $3.68. The Score for GROY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
GROY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Moderna, Inc. (MRNA)
is a Sell
Is Moderna, Inc. a Buy, Sell or Hold?
-
The current Moderna, Inc. [MRNA] share price is $49.20. The Score for MRNA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
MRNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GROY Stock Price Chart
What is Gold Royalty Corp.'s stock price today?
-
The Gold Royalty Corp. share price today is $3.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GROY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRNA Stock Price Chart
What is Moderna, Inc.'s stock price today?
-
The Moderna, Inc. share price today is $49.20The current trend is moderately bearish and MRNA is experiencing slight selling pressure.
GROY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 47.12 | Sell |
| Chaikin Money Flow: | 1104017 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.34 - 4.32) | Sell |
| Bollinger Bands (100): | (3.66 - 4.6) | Sell |
MRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 46.04 | Sell |
| Chaikin Money Flow: | -422045 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.34 - 54.78) | Sell |
| Bollinger Bands (100): | (28.82 - 50.48) | Buy |
GROY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.42 | Buy |
| 20-day SMA: | 3.67 | Buy |
| 50-day SMA: | 4.16 | Sell |
| 200-day SMA: | 3.65 | Buy |
| 8-day EMA: | 3.45 | Buy |
| 20-day EMA: | 2.78 | Buy |
| 50-day EMA: | 1.66 | Buy |
| 200-day EMA: | 0.52 | Buy |
MRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.78 | Sell |
| 20-day SMA: | 52.31 | Sell |
| 50-day SMA: | 49.09 | Buy |
| 200-day SMA: | 33.54 | Buy |
| 8-day EMA: | 50.49 | Sell |
| 20-day EMA: | 51.09 | Sell |
| 50-day EMA: | 48.04 | Buy |
| 200-day EMA: | 39.22 | Buy |
Gold Royalty Corp. Earnings Growth & GROY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.01 per share, an increase this year of $0.08 per share, and an increase next year of $0.06 per share.
Moderna, Inc. Earnings Growth & MRNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $1.29 per share, an increase this year of $0.93 per share, and an increase next year of $2.33 per share.
Gold Royalty Corp. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Moderna, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||